EFFECTS OF ANTIEPILEPTIC DRUGS AND ORGANIC BRAIN-DAMAGE ON SCE FREQUENCY IN CEREBRAL PALSIES

被引:1
作者
YAMAMOTO, K
KOHNOSU, T
NAKAGAWARA, K
SAKAI, K
机构
[1] NATL NISHITAGA HOSP, DEPT PEDIAT, SENDAI 982, JAPAN
[2] NATL NISHITAGA HOSP, DEPT NEUROL, SENDAI 982, JAPAN
[3] NATL NISHITAGA HOSP, CHROMOSOME ANAL LAB, SENDAI 982, JAPAN
关键词
SISTER CHROMATID EXCHANGE (SCE); ANTIEPILEPTIC DRUG; CEREBRAL PALSY; BRAIN DAMAGE;
D O I
10.1620/tjem.162.169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to assess the genotoxic effects of antiepileptic drugs (AEDs), analysis of sister chromatid exchanges (SCEs) was performed in lymphocytes of three groups of males; epileptics with AED therapy, non-epileptics without AED therapy and healthy controls. The epileptics and non-epileptics were cases of severe cerebral palsies due to perinatal asphyxia. Possible confounding factors of SCE frequencies, such as age, smoking habit, drug usage other than AED, recent history of viral infection, etc. were controlled. The frequency of SCE per cell was 4.63 +/- 0.71 (mean +/- S.D.) in epileptics, 4.70 +/- 0.89 in non-epileptics and 3.84 +/- 0.56 in healthy controls. SCEs in both epileptics and non-epileptics were significantly higher (p < 0.05) than those in controls. There was no significant difference of SCE frequency between epileptics and non-epileptics. These results suggested that no mutagenic effect of AED could be demonstrated as revealed by SCEs, and organic brain damage per se might influence the baseline SCE frequency. The possible explanations for such observations are discussed.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 22 条
[1]  
CARRANO AV, 1982, MUTAGENICITY NEW HOR, P267
[2]   BASELINE FREQUENCY OF SISTER-CHROMATID EXCHANGES (SCE) IN NEWBORN LYMPHOCYTES AND ITS RELATIONSHIP TO INVIVO AGING IN HUMANS [J].
DAS, BC ;
RANI, R ;
MITRA, AB ;
LUTHRA, UK .
MUTATION RESEARCH, 1985, 144 (02) :85-88
[3]   VARIATION IN SISTER-CHROMATID EXCHANGE AMONG 106 MEMBERS OF THE GENERAL UK POPULATION [J].
DEWDNEY, RS ;
LOVELL, DP ;
JENKINSON, PC ;
ANDERSON, D .
MUTATION RESEARCH, 1986, 171 (01) :43-51
[4]   MUTAGENIC RISK IN EPILEPTIC PATIENTS BEFORE AND AFTER ANTICONVULSANT THERAPY [J].
GOYLE, S ;
MAURYA, AK ;
KAILASH, S ;
MAHESHWARI, MC .
EPILEPSIA, 1987, 28 (01) :81-86
[5]  
GURON CS, 1985, INDIAN J MED RES, V82, P468
[6]   INCREASED SISTER CHROMATID EXCHANGES IN EPILEPTIC CHILDREN DURING LONG-TERM THERAPY WITH PHENYTOIN [J].
HABEDANK, M ;
ESSER, KJ ;
BRULL, D ;
KOTLAREK, F ;
STUMPF, C .
HUMAN GENETICS, 1982, 61 (01) :71-72
[7]  
HUNKE MH, 1978, AM J HUM GENET, V30, P1
[8]   SISTER CHROMATID EXCHANGE FREQUENCY CORRELATES WITH AGE, SEX AND CIGARETTE-SMOKING IN A 5-YEAR MATERIAL OF 553 HEALTHY-ADULTS [J].
HUSUM, B ;
WULF, HC ;
NIEBUHR, E .
HEREDITAS, 1986, 105 (01) :17-21
[9]   MUTAGENICITY OF ANTIEPILEPTIC DRUGS .1. CARBAMAZEPINE AND SOME OF ITS METABOLITES [J].
KONIGSTEIN, M ;
LARISCH, M ;
OBE, G .
MUTATION RESEARCH, 1984, 139 (02) :83-86
[10]   CHROMOSOMAL STUDIES OF PERIPHERAL-BLOOD FROM EPILEPTIC PATIENTS TREATED WITH PHENOBARBITAL AND OR DIPHENYLHYDANTOIN [J].
KULKARNI, PS ;
MONDKAR, VP ;
SONAWALLA, AB ;
AMBANI, LM .
FOOD AND CHEMICAL TOXICOLOGY, 1984, 22 (12) :1009-1012